Holo Secures €1 Million To Expand Personalized Lab Testing And Health Tracking

The app combines advanced lab testing, AI, and functional medicine, integrating with devices like the Apple Watch, Garmin, and Oura for a comprehensive health management experience.

The round was led by Calm/Storm Ventures and Mission VC, with participation from ENISA and a group of business angels and early customers of the company, including Javier López and Emilio Nicolás (Magnific AI, Freepik), Carlos Villanueva (Google), Álex Rodríguez (MarsBased), Álvaro López (Polygon Labs), Samuel Fernández and Sergi Molins (Factorial), José de Cabo (Olapic, Remotely Works), Esteve Almirall (Node Living), and Luis Sanz (Carto).

“Health should be something we understand not something we ignore until something goes wrong. At Holo, we want everyone to have control over their well-being as easily as they manage their finances. We want to create the Revolut of health,” explains Francesc Navarro, CEO and co-founder.

In 2025, several European startups focused on preventive health, diagnostics, and longevity announced new funding rounds in similar sectors.

Read Also - Belgium’s Rookoo Raises €900K To Streamline The Global Event Industry

Aeon from Switzerland raised €8.2 million to expand its AI-driven platform that integrates whole-body MRI, biomarkers, and genetics for preventive health. Blue Longevity Clinic in Bulgaria secured €2 million to grow its longevity-medicine clinics across Southeast Europe.

Epigenica in Sweden raised €1.8 million to advance its high-throughput epigenetic screening tools. Skleo Health from Germany closed a €3 million Seed round to scale its AI-powered preventive eye-screening platform, while MELP in Lithuania raised €1.25 million to expand its employee well-being and longevity platform in the UK.

Together, these rounds total around €16.25 million in sector-relevant funding.

In this context, Holo's pre-Seed round contributes to a growing trend of European startup funding in preventive health, diagnostics, longevity, and consumer health platforms.

Though Holo is in its early stages and has a smaller funding round compared to some peers, its Barcelona-based location adds valuable representation to Spain’s health-tech ecosystem, a country not currently well-represented in this space.

The presence of larger funding rounds for other companies shows strong investor interest in preventive health. Holo’s focus on wearable integration, lab biomarkers, and functional medicine aligns well with the industry’s shift toward proactive health monitoring rather than reactive care.

“In the coming years, everyone will have a complete profile of their health in their pocket. That information won’t just prevent disease it will help people live better every day. Holo will be the platform that makes it possible,” says Emilio Rodríguez, co-founder and Chief Product Officer.

Holo, founded in 2024 by Francesc Navarro, Emilio Rodríguez, and Sergio Mosquera, all former team members of the Barcelona-based unicorn Factorial, was built on a simple yet powerful idea: health doesn’t start in a hospital, it starts in daily life.

The platform allows users to undergo comprehensive lab tests at leading laboratories, connect their wearables, and receive personalized medical reports reviewed by doctors specializing in prevention and longevity.

Each user gets a dynamic health map, analyzing over 110 biomarkers related to everything from inflammation and hormones to longevity. This holistic approach helps users identify potential health risks before symptoms appear and optimize their energy and well-being in everyday life.

“The combination of science, technology, and user experience can transform the way we live. Our purpose is to create a new standard in prevention and well-being,” adds Sergio Mosquera, CTO and co-founder.

With this pre-seed round, Holo aims to solidify its position in Spain and prepare for its European expansion in 2026. The funds will be used for product development, new medical integrations, and establishing clinical collaborations across Europe.

In Spain, Holo already has a close partnership with Laboratorios Echevarne. The company is also working on developing new complementary services and personalized longevity programs, further reinforcing its vision to become the leading preventive health platform in Europe.

“From our very first meeting, we were impressed by the team’s executional excellence and product and engineering expertise gained during their time scaling Factorial, one of Europe’s leading tech unicorns. With Holo, they’re applying that same discipline and speed to the fast-growing preventive-health and longevity space a market driven by rising consumer demand and still underserved in Europe,” shares Lucanus Polagnoli, General Partner at Calm/Storm Ventures.

About Holo

Holo is your all-in-one health membership that empowers you to take control of your well-being. With over 110 lab tests and an AI-powered app, it consolidates your health data, from lab results to daily activity. Access top doctors, tests, and supplements all in one place.